Glutathione vs FOXO4-DRI
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: L-Glutathione, GSH
The body's master antioxidant - a tripeptide composed of glutamate, cysteine, and glycine. Found in every cell at concentrations similar to glucose (5mM). Essential for detoxification, immune function, and cellular protection against oxidative stress.
Also: FOX04-DRI, FOXO4 D-Retro-Inverso
A senolytic peptide designed to selectively eliminate senescent 'zombie' cells by disrupting the FOXO4-p53 interaction. Shows promise for restoring tissue function in aging, including kidney health restoration.
Key Comparison Insights
- Both peptides belong to the Anti-Aging category, suggesting similar primary applications.
- Glutathione has stronger research evidence (Human Trials) compared to FOXO4-DRI (Animal Studies).
Detailed Comparison
| Attribute | Glutathione | FOXO4-DRI |
|---|---|---|
| Category | Anti-Aging | Anti-Aging |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Glutathione directly neutralizes free radicals including superoxide, hydroxyl radicals, and nitric oxide. It regenerates other antioxidants like vitamins C and E. Through glutathione peroxidase enzymes, it detoxifies peroxides and lipid peroxides. The GSH/GSSG ratio (typically >100:1 in healthy cells) determines cellular redox status. Also critical for Phase II liver detoxification, binding toxins for excretion. | FOXO4-DRI is a D-retro-inverso peptide that interferes with the binding between FOXO4 and p53 proteins. In senescent cells, FOXO4 binds to p53 to prevent apoptosis, allowing these dysfunctional cells to persist. FOXO4-DRI competes for this binding, releasing p53 to trigger apoptosis specifically in senescent cells while sparing healthy cells. |
| Common Dosing | 500-1000 mg daily (oral or liposomal) 1-2x daily | 2-10 mg every other day for 3 doses (one cycle) 3 doses every other day, 1-3 cycles per year |
| Administration | Oral, liposomal, IV, or subcutaneous | Subcutaneous injection (community), IV/IP in animal studies |
| Typical Duration | Ongoing supplementation or 4-12 week courses | 1 cycle = 3 doses over 5-6 days, repeat 1-3x yearly |
| Best Time to Take | Morning on empty stomach, or evening | Per research protocol |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Extensive research across multiple therapeutic areas. Clinical trials show benefits for liver health, skin lightening (via melanin modulation), neurodegenerative conditions, and immune support. FDA grants GRAS status for food use. Studies on Parkinson's patients showed symptom improvement with IV administration. Liposomal forms show improved bioavailability in clinical studies. | Landmark 2017 Cell study demonstrated that FOXO4-DRI restored fitness, fur density, and renal function in aged mice. Studies show improved kidney tubular cell markers, better urea/creatinine metrics, and reduced SASP (senescence-associated secretory phenotype) cytokines. A 2025 Nature Communications study provided detailed structural insights into the FOXO4-p53 interaction mechanism. Cleara Biotech is developing FOXO4-DRI for conditions including kidney disease, COPD, and osteoarthritis. |
Frequently Asked Questions: Glutathione vs FOXO4-DRI
What is the difference between Glutathione and FOXO4-DRI?
Glutathione is a anti-aging peptide that the body's master antioxidant - a tripeptide composed of glutamate, cysteine, and glycine. found in every cell at concentrations similar to glucose (5mm). essential for detoxification, immune function, and cellular protection against oxidative stress. FOXO4-DRI is a anti-aging peptide that a senolytic peptide designed to selectively eliminate senescent 'zombie' cells by disrupting the foxo4-p53 interaction. shows promise for restoring tissue function in aging, including kidney health restoration. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Glutathione or FOXO4-DRI?
Neither is universally "better" - the choice depends on your specific goals. Glutathione is typically used for anti-aging purposes, while FOXO4-DRI is used for anti-aging. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Glutathione and FOXO4-DRI be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Glutathione and FOXO4-DRI together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.
Related Comparisons
View Full Peptide Profiles
Educational Information Only
This comparison of Glutathione and FOXO4-DRI is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.